Point-of-care immunotesting: Approaching the analytical performance of central laboratory methods
Tóm tắt
Từ khóa
Tài liệu tham khảo
Blick, 1999, Current trends in automation of immunoassays, J. Clin. Ligand Assay, 22, 6
St-Louis, 2000, Status of point-of-care testing: promise, realities, and possibilities, Clin. Biochem., 33, 427, 10.1016/S0009-9120(00)00138-7
Price, 2004, Point-of-care testing: what, why, when and where?, 3
Hardy, 2004, Point-of-care testing in patient transport settings, 221
Kirkbride, 2004, Point-of-care testing in the community, 353
Drenck, 2001, Point of care testing in critical care medicine: the clinician's view, Clin. Chim. Acta, 307, 3, 10.1016/S0009-8981(01)00448-X
Cabrera, 1969, A comprehensive evaluation of pregnancy tests, Am. J. Obstet. Gynecol., 103, 32, 10.1016/S0002-9378(16)34336-8
Kendall, 1998, Point of care testing: randomised controlled trial of clinical outcome, BMJ, 316, 1052, 10.1136/bmj.316.7137.1052
Kost, 1999, The laboratory-clinical interface: point-of-care testing, Chest, 115, 1140, 10.1378/chest.115.4.1140
Ono, 2003, A highly sensitive quantitative immunochromatography assay for antigen-specific IgE, J. Immunol. Methods, 272, 211, 10.1016/S0022-1759(02)00504-5
Adachi, 2002, Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection, J. Gastroenterol., 37, 703, 10.1007/s005350200115
Hudson, 1999, Cardiac markers: point of care testing, Clin. Chim. Acta, 284, 223, 10.1016/S0009-8981(99)00083-2
Stivers, 2000, A miniaturized self-contained single-use disposable quantitative test for hemoglobin A1c in blood at the point of care, Diabetes Technol. Ther., 2, 517, 10.1089/15209150050501916
Song, 2003, One-step immunoassay for acetaminophen and salicylate in serum, plasma, and whole blood, J. Anal. Toxicol., 27, 366, 10.1093/jat/27.6.366
George, 2002, Use of on-site testing for drugs of abuse, Clin. Chem., 48, 1639, 10.1093/clinchem/48.10.1639
Davies, 2003, Human chorionic gonadotropin testing for early pregnancy viability and complications, Clin. Lab. Med., 23, 257, 10.1016/S0272-2712(03)00026-X
Seamark, 2003, Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein, Ann. Clin. Biochem., 40, 178, 10.1258/000456303763046139
Sorell Gómez, 1997, A simple visual immunoassay (VIA) for rapid identification of high lipoprotein(a) blood levels, Clin. Chim. Acta, 260, 65, 10.1016/S0009-8981(96)06500-X
Anderson, 2000, Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing, J. Emerg. Med., 19, 225, 10.1016/S0736-4679(00)00225-0
Jung, 1999, Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared, Urology, 53, 155, 10.1016/S0090-4295(98)00419-1
Apple, 1999, Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction, Clin. Chem., 45, 199, 10.1093/clinchem/45.2.199
Ng, 2001, Ninety-minute accelerated critical pathway for chest pain evaluation, Am. J. Cardiol., 88, 611, 10.1016/S0002-9149(01)01801-X
Rosen, 2004, Market outlook for IVDs, IVD Tech., 10, 39
Roy, 2004, Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T, Int. J. Cardiol., 97, 297, 10.1016/j.ijcard.2004.05.042
Chan, 2003, Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein, J. Immunol. Methods, 279, 91, 10.1016/S0022-1759(03)00243-6
Mauron, 1998, SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients, Thromb. Haemost., 79, 1217, 10.1055/s-0037-1615046
Chen, 2002, No difference of accuracy between capillary and venous blood in rapid whole blood test for diagnosis of Helicobacter pylori infection, Dig. Dis. Sci., 47, 2519, 10.1023/A:1020516211030
Davis G, Lauks IR, Lin C, Miller CJ. Apparatus and methods for analyte measurement and immunoassay. US Patent Application 2003/170881, 2003.
Dahler-Eriksen, 1997, Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots, Clin. Chem., 43, 2064, 10.1093/clinchem/43.11.2064
Tisone, 2000, In-line manufacturing for rapid-flow diagnostic devices, IVD Tech., 6, 43
Heeschen, 1999, Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain, Clin. Chem., 45, 1789, 10.1093/clinchem/45.10.1789
Alfthan, 1992, Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women, Clin. Chem., 38, 1981, 10.1093/clinchem/38.10.1981
Rivier, 2000, Techniques for analytical testing of unconventional samples, Bailliere's Best Pract. Res. Clin. Endocrinol. Metab., 14, 147, 10.1053/beem.2000.0060
Fraser, 2001, Optimal analytical performance for point of care testing, Clin. Chim. Acta, 307, 37, 10.1016/S0009-8981(01)00429-6
Alpert, 2000, Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J. Am. Coll. Cardiol., 36, 959, 10.1016/S0735-1097(00)00804-4
Delaney, 2000, Near-patient tests in primary care: setting the standards for evaluation, J. Health Serv. Res. Policy, 5, 37, 10.1177/135581960000500109
Dati, 1997, Quality management and international standardization programs for protein immunoassays, Anticancer Res., 17, 3161
Price, 1998, Progress in immunoassay technology, Clin. Chem. Lab. Med., 36, 341, 10.1515/CCLM.1998.057
Jacobs, 2001, Implementation, management and continuous quality improvement of point-of-care testing in an academic health care setting, Clin. Chim. Acta, 307, 49, 10.1016/S0009-8981(01)00432-6
Halpern, 2000, Point of care diagnostics and networks, Crit. Care Clin., 16, 623, 10.1016/S0749-0704(05)70137-8
Blick, 2001, The essential role of information management in point-of-care/critical care testing, Clin. Chim. Acta, 307, 159, 10.1016/S0009-8981(01)00460-0
Stephans, 1999, Developing open standards for point-of-care connectivity, IVD Tech., 5, 22
St John, 2001, A connectivity standard for point-of-care testing, Med. Device Technol., 12, 23
Phillips, 2004, Unit-use quality control, 147
Gruszecki, 2003, Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: six years of experience, Clin. Chem., 49, 1017, 10.1373/49.6.1017
Cramb, 2004, Guidelines for point-of-care testing, 155
Demers, 2004, Regulatory issues regarding point-of-care testing, 163
Whitley, 2001, Establishing a quality management system for unit-use testing based on NCCLS proposed guideline (EP18-P), Clin. Chim. Acta, 307, 145, 10.1016/S0009-8981(01)00446-6
Ehrmeyer, 2001, Electronic “Quality Control” (EQC): is it just for unit use devices?, Clin. Chim. Acta, 307, 95, 10.1016/S0009-8981(01)00438-7
Westgard, 2001, Electronic quality control, the total testing process, and the total quality control system, Clin. Chim. Acta, 307, 45, 10.1016/S0009-8981(01)00430-2
Nichols, 1999, Quality assurance, practical management, and outcomes of point-of-care testing: laboratory perspectives: I. Part, Clin. Lab. Manage. Rev., 13, 341
de Monyé, 1999, Observer dependency of the SimpliRed D-dimer assay in 81 consecutive patients with suspected pulmonary embolism, Thromb. Res., 96, 293, 10.1016/S0049-3848(99)00118-8
Granade, 2004, Performance of the OraQuick and Hema-Strip rapid HIV antibody detection assays by non-laboratorians, J. Clin. Virol., 30, 229, 10.1016/j.jcv.2003.12.006
Jacobs, 2001, Implementation, management and continuous quality improvement of point-of-care testing in an academic health care setting, Clin. Chim. Acta, 307, 49, 10.1016/S0009-8981(01)00432-6
Jahn, 2003, Near-patient testing—point-of-care or point of costs and convenience?, Br. J. Anaesth., 90, 425, 10.1093/bja/aeg082
Foster, 2001, Point-of-care testing. Cost issues and impact on hospital operations, Clin. Lab. Med., 21, 269, 10.1016/S0272-2712(18)30034-9
Price, 2002, Medical and economic outcomes of point-of-care testing, Clin. Chem. Lab. Med., 40, 246, 10.1515/CCLM.2002.040
Keffer, 2004, Health economic aspects of point-of-care testing, 179
Kost, 1995, Guidelines for point-of-care testing. Improving patient outcomes, Am. J. Clin. Pathol., 104, S111
Kilgore, 1998, Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction, Clin. Chem., 44, 1597, 10.1093/clinchem/44.8.1597
Murray, 1999, Effect of point of care testing on length of stay in an adult emergency department, J. Emerg. Med., 17, 811, 10.1016/S0736-4679(99)00107-9
Lee-Lewandrowski, 2003, Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay, Arch. Pathol. Lab. Med., 127, 456, 10.5858/2003-127-0456-IOAPSL
McCord, 2001, Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I, Circulation, 104, 1483, 10.1161/hc3801.096336
Grieve, 1999, Near patient testing in diabetes clinics: appraising the costs and outcomes, Health Technol. Assess., 3, 1, 10.3310/hta3150
Dahler-Eriksen, 1999, Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes, Clin. Chem., 45, 478, 10.1093/clinchem/45.4.478
Krentz, 2004, Point-of-care testing in diabetes mellitus, 309
Cagliero, 1999, Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients, Diabetes Care, 22, 1785, 10.2337/diacare.22.11.1785
Thaler, 1999, Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making, Diabetes Care, 22, 1415, 10.2337/diacare.22.9.1415
Chaudhry, 2004, Patient satisfaction with point-of-care international normalized ratio testing and counseling in a community internal medicine practice, Manag. Care Interface, 17, 44
Davies, 2003, Streptococcus grouping latex kits: evaluation of five commercially available examples, Br. J. Biomed. Sci., 60, 136, 10.1080/09674845.2003.11783689
Kemp, 1988, Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood, Science, 241, 1352, 10.1126/science.3413497
Waaler, 1940, On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles, Acta Pathol. Microbiol. Scand., 17, 172, 10.1111/j.1699-0463.1940.tb01475.x
Rose, 1948, Differential agglutination of normal and sensitised sheep erythrocytes by sera of patients with rheumatoid arthritis, Proc. Soc. Exp. Biol. Med., 68, 1, 10.3181/00379727-68-16375
Gupta, 2003, Whole-blood agglutination assay for on-site detection of human immunodeficiency virus infection, J. Clin. Microbiol., 41, 2814, 10.1128/JCM.41.7.2814-2821.2003
John, 1990, The simpliRED D dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood, Thromb. Res., 58, 273, 10.1016/0049-3848(90)90097-V
Thompson, 1997, Kinetics and proposed mechanism of the reaction of an immunoinhibition, particle-enhanced immunoassay, Clin. Chem., 43, 2384, 10.1093/clinchem/43.12.2384
Arsie, 2000, Evaluation of diagnostic reliability of DCA 2000 for rapid and simple monitoring of HbA1c, Acta Diabetol., 37, 1, 10.1007/s005920070028
Kasahara, 1997, Simple devices and their possible application in clinical laboratory downsizing, Clin. Chim. Acta, 267, 87, 10.1016/S0009-8981(97)00179-4
Fitzpatrick J, Lenda RB. Chromatographic immunoassay device and method utilizing particle valency for quantification. US Patent 6,121,008; 2000.
Leung, 2003, One-step quantitative cortisol dipstick with proportional reading, J. Immunol. Methods, 281, 109, 10.1016/j.jim.2003.07.009
Müller-Bardorff, 1999, Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing, Clin. Chem., 45, 1002, 10.1093/clinchem/45.7.1002
Blatt, 1998, A miniaturized, self-contained, single-use, disposable assay device for the quantitative determination of the bone resorption marker, NTx, in urine, Clin. Chem., 44, 2051, 10.1093/clinchem/44.9.2051
Brooks, 1999, RAMP™: a rapid, quantitative whole blood immunochromatographic platform for point-of-care testing, Clin. Chem., 45, 1676, 10.1093/clinchem/45.9.1676
Wu, 2004, Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction, Clin. Chim. Acta, 346, 211, 10.1016/j.cccn.2004.03.036
Daniels RH, Watson AR. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels. US Patent Application 2002/0004246; 2002.
Niedbala, 2001, Detection of analytes by immunoassay using up-converting phosphor technology, Anal. Biochem., 293, 22, 10.1006/abio.2001.5105
LaBorde RT. Immunochromatographic assay method and apparatus. US Patent 6,607,922; 2003.
Yoon, 2003, Development of a membrane strip immunosensor utilizing ruthenium as an electro-chemiluminescent signal generator, Biosens. Bioelectron., 19, 289, 10.1016/S0956-5663(03)00207-0
Buechler KF. Diagnostic devices method and apparatus for the controlled movement of reagents without membranes. US Patent 6,271,040; 2001.
Khaira, 1998, Plasma D-dimer measurement in patients with suspected DVT—a means of avoiding unnecessary venography, Eur. J. Vasc. Endovasc. Surg., 15, 235, 10.1016/S1078-5884(98)80182-2
Crosby M. Methods for forming an optical device for detecting the presence or amount of an analyte. US Patent 5,629,214; 1997.
Rabbany, 1994, Optical immunosensors, Crit. Rev. Biomed. Eng., 22, 307
Ettinger, 1999, A new optical immunoassay for detection of S-100B protein in whole blood, Ann. Thorac. Surg., 68, 2196, 10.1016/S0003-4975(99)00849-8
Clark DD, Steaffens JW, Dorson J, et al. An automated point-of-care detection system including complete sample processing capabilities. US Patent 6,656,428; 2003.
St John, 2004, Benchtop instruments for point-of-care testing, 31
von Lode, 2004, Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood, Clin. Chem., 50, 1026, 10.1373/clinchem.2004.031922
Pagani, 2004, Innotrac aio! Second-generation cardiac troponin I assay: imprecision profile and other key characteristics for clinical use, Clin. Chem., 50, 1271, 10.1373/clinchem.2004.033258
Singh, 1994, Starburst dendrimers: enhanced performance and flexibility for immunoassays, Clin. Chem., 40, 1845, 10.1093/clinchem/40.9.1845
Christenson, 2004, Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations, Clin. Biochem., 37, 679, 10.1016/j.clinbiochem.2004.03.009
Luppa, 2001, Immunosensors—principles and applications to clinical chemistry, Clin. Chim. Acta, 314, 1, 10.1016/S0009-8981(01)00629-5
Aizawa, 1979, Enzyme immunosensor: III. Amperometric determination of human chorionic gonadotropin by membrane-bound antibody, Anal. Biochem., 94, 22, 10.1016/0003-2697(79)90784-X
Rowe, 1999, An array immunosensor for simultaneous detection of clinical analytes, Anal. Chem., 71, 433, 10.1021/ac980798t
Schult, 1999, Disposable optical sensor chip for medical diagnostics: new ways in bioanalysis, Anal. Chem., 71, 5430, 10.1021/ac9907686
Braach-Maksvytis VLB, Cornell BA, King LG, Raguse B. Detection device and method. US Patent 6,562,631; 2003.
Apple, 2004, Analytical performance of the i-STAT cardiac troponin I assay, Clin. Chim. Acta, 345, 123, 10.1016/j.cccn.2004.03.010
Papadea, 2002, Evaluation of the i-STAT portable clinical analyzer for point-of-care blood testing in the intensive care units of a university children's hospital, Ann. Clin. Lab. Sci., 32, 231
Lopez Silva, 2003, Near-infrared transmittance pulse oximetry with laser diodes, J. Biomed. Opt., 8, 525, 10.1117/1.1578495
Soini, 2000, Two-photon fluorescence excitation in detection of biomolecules, Biochem. Soc. Trans., 28, 70, 10.1042/bst0280070
Waris, 2002, Two-photon excitation fluorometric measurement of homogeneous microparticle immunoassay for C-reactive protein, Anal. Biochem., 309, 67, 10.1016/S0003-2697(02)00256-7
Hirsch, 2003, A whole blood immunoassay using gold nanoshells, Anal. Chem., 75, 2377, 10.1021/ac0262210
Soukka T. Immunoassay designs and potential of particulate photoluminescent lanthanide reporters. Doctoral thesis. Department of Biotechnology, University of Turku, Finland; 2003.
Ullman, 1996, Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method, Clin. Chem., 42, 1518, 10.1093/clinchem/42.9.1518
Dafforn, 2000, Miniaturization of the luminescent oxygen channeling immunoassay (LOCI™) for use in multiplex array formats and other biochips, Clin. Chem., 46, 1495, 10.1093/clinchem/46.9.1495
Kricka, 2001, Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century, Clin. Chim. Acta, 307, 219, 10.1016/S0009-8981(01)00451-X
Jain, 2004, Applications of biochips: from diagnostics to personalized medicine, Curr. Opin. Drug Discov. Devel., 7, 285
Pavlickova, 2004, Advances in recombinant antibody microarrays, Clin. Chim. Acta, 343, 17, 10.1016/j.cccn.2004.01.009
Gorman, 1997, An overview of immunoassay automation, 299
Wiese, 2001, Simultaneous multianalyte ELISA performed on a microarray platform, Clin. Chem., 47, 1451, 10.1093/clinchem/47.8.1451
Kingsmore, 2003, Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification, Curr. Opin. Biotechnol., 14, 74, 10.1016/S0958-1669(02)00019-8
Saviranta, 2004, Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime, Clin. Chem., 50, 1907, 10.1373/clinchem.2004.037929
Ressine, 2003, Macro-/nanoporous silicon as a support for high-performance protein microarrays, Anal. Chem., 75, 6968, 10.1021/ac034425q
Wang, 2002, Array-based multiplexed screening and quantitation of human cytokines and chemokines, J. Proteome Res., 1, 337, 10.1021/pr0255203
Chetcuti, 1999, An indirect perfluorosulfonated ionomer-coated electrochemical immunosensor for the detection of the protein human chorionic gonadotrophin, Anal. Chem., 71, 4088, 10.1021/ac981216a
Purvis, 2003, An ultrasensitive and stable potentiometric immunosensor, Biosens. Bioelectron., 18, 1385, 10.1016/S0956-5663(03)00066-6
Meyerhoff, 1995, Novel nonseparation sandwich-type electrochemical enzyme immunoassay system for detecting marker proteins in undiluted blood, Clin. Chem., 41, 1378, 10.1093/clinchem/41.9.1378
Dai, 2004, Novel amperometric immunosensor for rapid separation-free immunoassay of carcinoembryonic antigen, J. Immunol. Methods, 287, 13, 10.1016/j.jim.2004.01.012
Burdick, 2002, Evanescent-wave biosensors, 187
Plowman, 1999, Multiple-analyte fluoroimmunoassay using an integrated optical waveguide sensor, Anal. Chem., 71, 4344, 10.1021/ac990183b
Homola, 2003, Present and future of surface plasmon resonance biosensors, Anal. BioAnal. Chem., 377, 528, 10.1007/s00216-003-2101-0
Vikholm I, Sadowski J. Method and biosensor for analysis. US Patent Application 2003/0059954; 2003.
Chou, 2004, Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance, Biosens. Bioelectron., 19, 999, 10.1016/j.bios.2003.09.004
Tüdös, 2001, Trends in miniaturized total analysis systems for point-of-care testing in clinical chemistry, Lab. Chip., 1, 83, 10.1039/B106958F
Lee, 2004, Micro total analysis system (micro-TAS) in biotechnology, Appl. Microbiol. Biotechnol., 64, 289, 10.1007/s00253-003-1515-0
Jianrong, 2004, Nanotechnology and biosensors, Biotechnol. Adv., 22, 505, 10.1016/j.biotechadv.2004.03.004
Silver JH, Mostowfi DF. Implantable, retrievable sensors and immunosensors. US Patent Application 2003/0114735; 2003.
Bissell, 2002, Empowering patients with point-of-care testing, Trends Biotechnol., 20, 269, 10.1016/S0167-7799(02)01961-3
Crosby, 2002, IVDs for home-use testing: issues in diagnosis and monitoring, IVD Tech., 8, 18
Lehmann, 2002, The future of home testing—implications for traditional laboratories, Clin. Chim. Acta, 323, 31, 10.1016/S0009-8981(02)00181-X
Celler, 2003, Using information technology to improve the management of chronic disease, Med. J. Aust., 179, 242, 10.5694/j.1326-5377.2003.tb05529.x